Catheter Precision announced its first purchase order from a hospital in the greater Chicago area. As previously announced, the company has recently expanded their US sales and clinical team in preparation for the national product launch of LockeT which includes the Chicago region. The newest purchase order comes from one of the hospitals within the the Endeavor Health System, which includes 9 hospitals, more than 300 care sites and over 7,100 physicians, making it the third largest healthcare system in Illinois.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTAK:
- Catheter Precision reports Q2 EPS ($5.57) vs. ($2.94) last year
- Catheter Precision announces publication of LockeT data
- Catheter Precision Converts Series A Preferred Stock
- Catheter Precision completes enrollment of 75 patients in LockeT-II study
- Catheter Precision completes patient follow-up for VIVO European Registry